Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Concerns with the new biological research criteria for synucleinopathy.

Boeve BF. et al, (2024), Lancet Neurol, 23, 659 - 660

Genome-wide determinants of mortality and motor progression in Parkinson's disease.

Tan MMX. et al, (2024), NPJ Parkinsons Dis, 10

Online cognitive monitoring technology for people with Parkinson's disease and REM sleep behavioural disorder.

Bălăeţ M. et al, (2024), NPJ Digit Med, 7

Genome sequence analyses identify novel risk loci for multiple system atrophy.

Chia R. et al, (2024), Neuron

Automated quality control of T1-weighted brain MRI scans for clinical research: methods comparison and design of a quality prediction classifier

Bhalerao GV. et al, (2024)

RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.

Gustavsson EK. et al, (2024), Lancet Neurol

Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years.

Gandhi SE. et al, (2024), Mov Disord Clin Pract

Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.

Arnaldi D. et al, (2024), Ann Neurol

Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.

Kobylecki C. et al, (2024), Eur J Neurol

Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression.

Lawton M. et al, (2024), Eur J Epidemiol

Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.

Marras C. et al, (2024), Mov Disord

A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase.

Gustavsson EK. et al, (2024), medRxiv

Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy.

Pavelka L. et al, (2024), Brain Commun, 6

Metacognitive accuracy differences in Parkinson's disease and REM sleep behavioral disorder relative to healthy controls.

Bălăeţ M. et al, (2024), Front Neurol, 15

Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease

Yan S. et al, (2024), JAMA Neurology, 81, 59 - 59

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.

Pachchek S. et al, (2023), NPJ Parkinsons Dis, 9

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Pachchek S. et al, (2023), npj Parkinson's Disease, 9

Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.

Gonzalez-Robles C. et al, (2023), Movement disorders : official journal of the Movement Disorder Society

Altered Impulsivity Across Drug-Naïve Parkinsonism, Isolated Rapid Eye Movement Sleep Behavior Disorder, and Their High-Risk Relatives.

Zhou L. et al, (2023), Ann Neurol

Investigating gait-responsive somatosensory cueing from a wearable device to improve walking in Parkinson's disease.

Li D. et al, (2023), Biomed Eng Online, 22

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?